Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Lilly synthesizes new phosphodiesterase PDE1 inhibitors

Feb. 26, 2019

Imarikiren improves albuminuria in patients with type 2 diabetes

Feb. 22, 2019

DDR1 inhibitor seen to prevent renal function loss in mice

Feb. 21, 2019

Positive data presented from phase II PHOENIX study of bardoxolone methyl

Feb. 21, 2019

Dual complement inhibition by CRIg/FH shows renoprotective effect in ischemia reperfusion injury

Feb. 18, 2019

New phase III study of empagliflozin assesses cardio-renal outcomes in chronic kidney disease

Feb. 8, 2019

First mouse kidneys grown from mouse stem cells in rats

Feb. 8, 2019

Nash Pharmaceuticals reports preclinical activity and new compounds for kidney disease

Jan. 15, 2019

Regulus reports preliminary interim data from mouse chronic toxicity study of RGLS-4326

Jan. 7, 2019

FDA accepts IND for phase Ib study of DM-199 for diabetes-related CKD

Jan. 3, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...